Li-li Fu

发表

Rosiglitazone attenuates development of polycystic kidney disease and prolongs survival in Han:SPRD rats.

Xuefei Shen, B. Dai, Yawei Liu, 2010, Clinical science.

Design, synthesis and antitumor evaluation of a new series of N-substituted-thiourea derivatives

Jian Li, Hong Liu, Bing Xiong, 2006, Acta Pharmacologica Sinica.

Scribble influences cyst formation in autosomal‐dominant polycystic kidney disease by regulating Hippo signaling pathway

C. Mei, Li-li Fu, Dechao Xu, 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Kruppel-Like Factor 15 Modulates Renal Interstitial Fibrosis by ERK/MAPK and JNK/MAPK Pathways Regulation

C. Mei, Li-li Fu, Xiang Gao, 2013, Kidney and Blood Pressure Research.

Concomitant use of rapamycin and rosiglitazone delays the progression of polycystic kidney disease in Han:SPRD rats: a study of the mechanism of action.

C. Mei, Li-li Fu, Xueqi Wang, 2018, American journal of physiology. Renal physiology.

Rosiglitazone Inhibits Transforming Growth Factor-β1 Mediated Fibrogenesis in ADPKD Cyst-Lining Epithelial Cells

B. Dai, Yawei Liu, C. Mei, 2011, PloS one.

DH9, a novel PPARγ agonist suppresses the proliferation of ADPKD epithelial cells: An association with an inhibition of β-catenin signaling

C. Mei, Li-li Fu, Xishan Xiong, 2010, Investigational New Drugs.

Efficacy of Short-Term High-Dose Statin in Preventing Contrast-Induced Nephropathy: A Meta-Analysis of Seven Randomized Controlled Trials

B. Dai, Yawei Liu, C. Mei, 2012, PloS one.

Oxidized high‐density lipoprotein enhances inflammatory activity in rat mesangial cells

C. Mei, Li-li Fu, Xiang Gao, 2010, Diabetes/Metabolism Research Reviews.

VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury.

Minjuan Wu, J. Xiong, Hou-qi Liu, 2011, American journal of physiology. Renal physiology.

Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15.

C. Mei, Li-li Fu, F. Grosjean, 2011, Kidney international.

SNX9 Inhibits Cell Proliferation and Cyst Development in Autosomal Dominant Polycystic Kidney Disease via Activation of the Hippo-YAP Signaling Pathway

Li-li Fu, Sheng-qiang Yu, Wutao Wang, 2020, Frontiers in Cell and Developmental Biology.

Identification of Key Genes and Candidated Pathways in Human Autosomal Dominant Polycystic Kidney Disease by Bioinformatics Analysis

Li-li Fu, C. Mei, L. Bu, 2019, Kidney and Blood Pressure Research.

Effects of polycystin‑1 N‑terminal fragment fusion protein on the proliferation and apoptosis of rat mesangial cells.

C. Mei, Li-li Fu, Ping Chen, 2014, Molecular Medicine Reports.

Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway.

Ming Wu, C. Mei, Li-li Fu, 2018, AJP - Renal Physiology.

Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis.

J. Privratsky, C. Mei, Li-li Fu, 2019, American journal of physiology. Renal physiology.

Interactions between Macrophages and Cyst-Lining Epithelial Cells Promote Kidney Cyst Growth in Pkd1-Deficient Mice.

Jie Zhou, C. Mei, Li-li Fu, 2018, Journal of the American Society of Nephrology : JASN.

Deletion of p18(INK4c) aggravates cisplatin-induced acute kidney injury.

Wei Chen, C. Mei, Li-li Fu, 2014, International journal of molecular medicine.

Overexpression of p18INK4C in LLC-PK1 cells increases resistance to cisplatin-induced apoptosis

C. Mei, Li-li Fu, Chunyan Liu, 2011, Pediatric Nephrology.

The Nephroprotective Effect of Tauroursodeoxycholic Acid on Ischaemia/Reperfusion‐Induced Acute Kidney Injury by Inhibiting Endoplasmic Reticulum Stress

C. Mei, Li-li Fu, Cheng-gang Xu, 2012, Basic & clinical pharmacology & toxicology.

Oxidized high-density lipoprotein impairs the function of human renal proximal tubule epithelial cells through CD36.

C. Mei, Li-li Fu, Cheng-gang Xu, 2014, International journal of molecular medicine.

In-center Nocturnal Hemodialysis Reduced the Circulating FGF23, Left Ventricular Hypertrophy, and All-Cause Mortality: A Retrospective Cohort Study

B. Dai, Yawei Liu, C. Mei, 2022, Frontiers in Medicine.

Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation.

C. Mei, Li-li Fu, Chunyan Liu, 2013, Molecular medicine reports.

Pyrimidinyl-arylpropionic acid derivatives: viable resources in the development of new antineoplastic agents

Jianhua Shen, B. Dai, C. Mei, 2010, Investigational New Drugs.

Antitumor activity of a novel series of α-aryloxy-α-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines

Jianhua Shen, B. Dai, C. Mei, 2009, Investigational New Drugs.

Comparison between effects of mycophenolate mofetil and rapamycin on proliferation and apoptosis of cyst-lining epithelial cells of ADPKD patients: Comparison between effects of mycophenolate mofetil and rapamycin on proliferation and apoptosis of cyst-lining epithelial cells of ADPKD patients

Li-li Fu, C. Mei, Tong Zhang, 2009 .

Cyclin-dependent kinase inhibitor p18INK4c is involved in protective roles of heme oxygenase-1 in cisplatin-induced acute kidney injury.

C. Mei, Li-li Fu, Liang Wang, 2014, International journal of molecular medicine.

KLF 15 Works as an Early Anti-Fibrotic Transcriptional Regulator in Ang II-Induced Renal Fibrosis via Down-Regulation of CTGF Expression

C. Mei, Li-li Fu, Yi Wang, 2017, Kidney & Blood Pressure Research.

Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease

Jie Zhou, Ming Wu, R. Wüthrich, 2017, Kidney and Blood Pressure Research.

B5, a novel pyrrole-substituted indolinone, exerts potent antitumor efficacy through G2/M cell cycle arrest

Xiao-min Luo, C. Mei, Li-li Fu, 2010, Investigational new drugs.

Inhibition of MiR-199a-5p Reduced Cell Proliferation in Autosomal Dominant Polycystic Kidney Disease through Targeting CDKN1C

Ming Wu, C. Mei, Li-li Fu, 2015, Medical science monitor : international medical journal of experimental and clinical research.

Antitumor activity of a novel EGFR tyrosine kinase inhibitor against human lung carcinoma in vitro and in vivo

Hualiang Jiang, C. Mei, Li-li Fu, 2009, Investigational New Drugs.

Low-protein diet supplemented with ketoacids delays the progression of diabetic nephropathy by inhibiting oxidative stress in the KKAy mice model.

Ming Wu, C. Mei, Li-li Fu, 2017, British Journal of Nutrition.

NS398 as a potential drug for autosomal‐dominant polycystic kidney disease: Analysis using bioinformatics, and zebrafish and mouse models

C. Mei, Li-li Fu, Z. Mao, 2021, Journal of Cellular and Molecular Medicine.

Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector

Li-li Fu, C. Mei, Jun Wu, 2015, Clinical science.

Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.

B. Dai, Yawei Liu, C. Mei, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway

Li-li Fu, C. Mei, C. Ye, 2012, Molecular Biology Reports.

Saikosaponin-d inhibits proliferation by up-regulating autophagy via the CaMKKβ–AMPK–mTOR pathway in ADPKD cells

C. Mei, Li-li Fu, Wei Zhou, 2018, Molecular and Cellular Biochemistry.